EXPLAINED: 6 | Rare Historical Photos

India’s patent law safeguards under fire

The new recommendation reduces the period within which patent applications can be challenged to six months

The Hindu · Jul 2, 2022

The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Jun 30, 2022

Novartis' Tislelizumab Extends Overall Survival In Late-Stage Esophageal Cancer Study

Novartis AG (NYSE: NVS) announced results from the Phase 3 RATIONALE 306 trial of tislelizumab plus chemotherapy in patients with unresectable, locally advanced recurrent or metastatic esophageal squamous cell carcinoma (ESCC).

Benzinga · Jun 30, 2022

Why Precision BioSciences Shares Are Surging Today

Precision BioSciences Inc (NASDAQ:DTIL) has entered into an exclusive worldwide in vivo gene editing research and development collaboration and license agreement with Novartis AG (NYSE:NVS)  Precision will develop a custom ARCUS nuclease that will be designed to insert, in vivo, a therapeutic transgene at a "safe harbor" location in the genome as a potential one-time…

Benzinga · Jun 22, 2022

Explained | The Indian patent regime and its clash with the U.S. norms

The U.S. Trade Representative highlighted IP challenges in India in its annual Special 301 report released last month

The Hindu · Jun 9, 2022

Firms rejig to survive in lean times

Businesses adopted cost reduction, increased productivity, and emphasised environmental standards to cope with the pandemic and global challenges stemming from the Russia-Ukraine war, panellists told the Forbes Thailand 2022 Forum on Monday.

Bangkok Post · Jun 6, 2022

Novartis drug combo shows promise in childhood brain cancer

An oral drug combination by Swiss pharmaceuticals company Novartis showed promise in treating a subgroup of patients suffering from a common childhood brain cancer in a trial.

Reuters · Jun 6, 2022

Work on environmental and economic Novartis 'leaving gift' legacy begins

Wetland habitat to be created to enable future inward investment and economic development at pace

Birmingham Post · May 30, 2022

KTR hardsells Telangana at Davos

Meets top honchos of tech and pharma companies

The Hindu · May 24, 2022

Buyer of Novartis Grimsby outlines what could be next for 'world-class' pharmaceutical complex

International Process Plants has taken it on under new subsidiary Humber Industrials Ltd - eyeing onshoring of production as a possibility

Birmingham Post · May 24, 2022